Pritesh Trivedi

678 total citations
20 papers, 402 citations indexed

About

Pritesh Trivedi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Pritesh Trivedi has authored 20 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Pritesh Trivedi's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Pritesh Trivedi is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Research Studies (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Pritesh Trivedi collaborates with scholars based in United Kingdom, Egypt and United States. Pritesh Trivedi's co-authors include David J. Pinato, Francesco Mauri, Rohini Sharma, James R. Black, Robert J. Shiner, Roberto Dina, Justin Stebbing, Sebastian Trousil, Kikkeri N. Naresh and Mona El‐Bahrawy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Kidney International.

In The Last Decade

Pritesh Trivedi

19 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pritesh Trivedi United Kingdom 11 189 139 97 88 83 20 402
K S Song South Korea 5 135 0.7× 274 2.0× 77 0.8× 124 1.4× 59 0.7× 12 486
Ricardo Alvarez United States 11 133 0.7× 92 0.7× 50 0.5× 58 0.7× 98 1.2× 20 374
Mildred Amaya United States 9 159 0.8× 134 1.0× 180 1.9× 78 0.9× 56 0.7× 20 665
Lambert J. C. M. Van den Broek Netherlands 11 126 0.7× 173 1.2× 74 0.8× 75 0.9× 195 2.3× 14 543
Hina Desai United States 10 127 0.7× 114 0.8× 177 1.8× 67 0.8× 46 0.6× 16 587
Samuel Suzuki United States 9 228 1.2× 214 1.5× 39 0.4× 102 1.2× 130 1.6× 22 460
Atsushi Shinagawa Japan 13 144 0.8× 142 1.0× 55 0.6× 39 0.4× 43 0.5× 39 446
Jacob Elebro Sweden 14 345 1.8× 155 1.1× 108 1.1× 101 1.1× 80 1.0× 28 492
Jamileh Hashemi Sweden 16 344 1.8× 252 1.8× 71 0.7× 114 1.3× 49 0.6× 26 575
M. M. Uttenreuther-Fischer Germany 13 198 1.0× 201 1.4× 143 1.5× 67 0.8× 57 0.7× 24 542

Countries citing papers authored by Pritesh Trivedi

Since Specialization
Citations

This map shows the geographic impact of Pritesh Trivedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pritesh Trivedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pritesh Trivedi more than expected).

Fields of papers citing papers by Pritesh Trivedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pritesh Trivedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pritesh Trivedi. The network helps show where Pritesh Trivedi may publish in the future.

Co-authorship network of co-authors of Pritesh Trivedi

This figure shows the co-authorship network connecting the top 25 collaborators of Pritesh Trivedi. A scholar is included among the top collaborators of Pritesh Trivedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pritesh Trivedi. Pritesh Trivedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robinson, Mark E., Valentina S. Caputo, Xiaolin Xiao, et al.. (2021). The innate sensor ZBP1-IRF3 axis regulates cell proliferation in multiple myeloma. Haematologica. 107(3). 721–732. 28 indexed citations
2.
3.
4.
Pinato, David J., Joanne Evans, Hua Zhang, et al.. (2020). Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine Tumours. Neuroendocrinology. 111(5). 465–474. 14 indexed citations
5.
Gerrard, Gareth, et al.. (2019). Targeted next generation sequencing of pancreatic solid pseudopapillary neoplasms show mutations in Wnt signaling pathway genes. Pathology International. 69(4). 193–201. 11 indexed citations
6.
Medjeral‐Thomas, Nicholas, Pritesh Trivedi, Kathleen Seyb, et al.. (2019). Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis. Kidney International. 95(3). 655–665. 34 indexed citations
7.
Foschi, Valentina, Daria Bortolotti, Pritesh Trivedi, et al.. (2019). Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study. Lupus. 28(9). 1091–1100. 2 indexed citations
8.
Mauri, Francesco, Robert J. Shiner, Elisa Suardi, et al.. (2018). The influence of HIV status on programmed-death ligands expression in non-small cell lung cancer. Lung Cancer. 115. S4–S4. 1 indexed citations
9.
Pinato, David J., James R. Black, Sebastian Trousil, et al.. (2017). Programmed cell death ligands expression in phaeochromocytomas and paragangliomas: Relationship with the hypoxic response, immune evasion and malignant behavior. OncoImmunology. 6(11). e1358332–e1358332. 56 indexed citations
10.
Pinato, David J., Robert J. Shiner, James R. Black, et al.. (2016). Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy. OncoImmunology. 5(9). e1213934–e1213934. 65 indexed citations
11.
Pinato, David J., Matthew Brown, Hua Zhang, et al.. (2016). Programmed cell death (PD-1) ligands expression in gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs): relationship with angiogenesis and clinical outcome.. Journal of Clinical Oncology. 34(15_suppl). e15658–e15658. 4 indexed citations
12.
Menter, Thomas, Pritesh Trivedi, Raida Ahmad, et al.. (2016). Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell Lymphomas. American Journal of Clinical Pathology. 147(3). 292–300. 17 indexed citations
13.
Romano, Cláudia, Mikel Valgañón, Maryou B. Lambros, et al.. (2016). The status of epidermal growth factor receptor in borderline ovarian tumours. Oncotarget. 7(9). 10568–10577. 7 indexed citations
14.
Pinato, David J., Robert J. Shiner, J Black, et al.. (2016). Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer (LC): Implications for immunotherapy.. Journal of Clinical Oncology. 34(15_suppl). 11601–11601.
15.
Taylor, Alexandra, Pritesh Trivedi, Yoshiya Horimoto, et al.. (2014). Expression profiling and significance of VEGF-A, VEGFR2, VEGFR3 and related proteins in endometrial carcinoma. Cytokine. 68(2). 94–100. 46 indexed citations
16.
Koulis, Athanasios, Pritesh Trivedi, Hazem Ibrahim, Mark Bower, & Kikkeri N. Naresh. (2014). The role of the microenvironment in human immunodeficiency virus‐associated classical Hodgkin lymphoma. Histopathology. 65(6). 749–756. 10 indexed citations
17.
Mauri, Francesco, David J. Pinato, Pritesh Trivedi, Rohini Sharma, & Robert J. Shiner. (2012). Isogeneic comparison of primary and metastatic lung cancer identifies CX3CR1 as a molecular determinant of site-specific metastatic diffusion. Oncology Reports. 28(2). 647–653. 14 indexed citations
18.
Lombardo, Ylenia, Aleksandra Filipović, Gemma Molyneux, et al.. (2012). Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo. Proceedings of the National Academy of Sciences. 109(41). 16558–16563. 69 indexed citations
19.
20.
Wagner, Simon D., Furrat Amen, Pritesh Trivedi, et al.. (2007). Bcl-6 and c-Myc are rarely co-expressed in adult diffuse large B-cell lymphoma. Leukemia & lymphoma. 48(8). 1510–1513. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K S Song Breakdown of academic impact, for papers by Ricardo Alvarez Breakdown of academic impact, for papers by Mildred Amaya Breakdown of academic impact, for papers by Lambert J. C. M. Van den Broek Breakdown of academic impact, for papers by Hina Desai Breakdown of academic impact, for papers by Samuel Suzuki Breakdown of academic impact, for papers by Atsushi Shinagawa Breakdown of academic impact, for papers by Jacob Elebro Breakdown of academic impact, for papers by Jamileh Hashemi Breakdown of academic impact, for papers by M. M. Uttenreuther-Fischer
Rankless by CCL
2026